|
|
 Acceleron to Present at the 7th Annual Biotechnology Industry Organization Investor ForumCAMBRIDGE, Mass. - October 24, 2008 – Acceleron Pharma, Inc., a biopharmaceutical company developing novel therapeutics that modulate the growth of tissues including bone and muscle, today announced that Steven Ertel, Vice President, Corporate Development of Acceleron, will provide a corporate presentation at the 7th Annual Biotechnology Investor Organization (BIO) Investor Forum on Wednesday, October 29, 2008 at 2:15 PM (PDT) at the Palace Hotel in San Francisco. About Acceleron Acceleron is a privately held biopharmaceutical company committed to discover, develop, manufacture and commercialize novel biotherapeutics that modulate the growth of bone, muscle, fat and the vasculature to treat musculoskeletal, metabolic and cancer-related diseases. Acceleron’s scientific approach takes advantage of its unique insight into the regenerative powers of the Growth and Differentiation Factor (GDF) family of proteins. ACE-011, a novel bone forming compound, is the Company’s lead compound and is being developed to reverse bone loss in diseases such as cancer-related bone loss in a strategic alliance with the multinational biopharmaceutical company Celgene Corporation. ACE-031, a novel muscle building compound, is being developed to increase muscle mass and strength. In addition, the company is advancing through preclinical development product candidates that control angiogenesis and inhibit fat accumulation. Acceleron utilizes proven biotherapeutic technologies and capitalizes on the company’s internal Good Manufacturing Practice (GMP) manufacturing capability to rapidly and efficiently advance its therapeutic programs. The investors in Acceleron are Advanced Technology Ventures, Bessemer Ventures, Flagship Ventures, MPM BioEquities, OrbiMed Advisors, Polaris Ventures, QVT Financial, Sutter Hill Ventures and Venrock. For more information, visit www.acceleronpharma.com. CONTACT: Paul Kidwell (Media) |
| Home|Privacy Policy|Site Map|Website design by Garfield Group | © 2009 Acceleron Pharma. All rights reserved. |